Pyrrolidine derivatives acting as ccr3-receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/12 (2006.01) A61K 31/4015 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2552928

Compounds of formula (I) in free or salt form, wherein T, X, Y, U, R1, R2, m, n and p have the meanings as indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

L'invention se rapporte à des composés de formule (I) sous forme libre ou sous forme de sel, qui peuvent servir à traiter des états dont la médiation est assurée par le récepteur CCR3. Dans ladite formule (I), T, X, Y, U, R?1¿, R?2¿,? ¿m, n et p sont tels que définis dans la description. Cette invention concerne en outre des compositions pharmaceutiques qui contiennent ces composés, ainsi que des procédés pour préparer lesdits composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolidine derivatives acting as ccr3-receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolidine derivatives acting as ccr3-receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine derivatives acting as ccr3-receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1845201

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.